Enzo Biochem reports Q2 revenue $7.3M vs. $6.2M in Q1
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 17 2025
0mins
Should l Buy ?
Q2 Revenue Performance: Enzo reported Q2 revenue of $7.3 million, an 18% increase from the previous quarter, but a 14% decline year-over-year due to large order fulfillment timing and a market slowdown in the US.
Financial Position: The company ended the second quarter with $40.3 million in cash and cash equivalents, with management focused on conserving cash.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
